Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,090,336
-$59,473,218 QoQ
Shares Held
972,258
-46.5% QoQ
Ownership
0.585%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#32
of 513 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. IONS ranks #14 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
6,185,970 | $115,739,498 |
All Filings in IONS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,090,336 | 972,258 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $136,563,554 | 1,818,665 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $379,901,962 | 4,802,199 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $408,511,983 | 6,244,451 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $310,279,852 | 7,853,198 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $236,930,983 | 7,853,198 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $275,089,752 | 7,868,700 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $315,448,464 | 7,874,400 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $393,692,284 | 8,260,434 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $359,783,931 | 8,299,514 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $440,840,602 | 8,713,987 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $418,840,632 | 9,233,700 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $384,873,709 | 9,380,300 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $339,955,306 | 9,511,900 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $368,027,103 | 9,743,900 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $418,566,182 | 9,463,400 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $361,927,066 | 9,776,528 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $367,365,423 | 9,918,073 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $315,106,392 | 10,355,123 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $313,529,437 | 9,347,926 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $396,117,471 | 9,930,245 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $403,931,160 | 8,984,234 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $511,692,201 | 9,050,092 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $413,587,010 | 8,716,270 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $486,412,511 | 8,249,873 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $396,189,473 | 8,379,642 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||